<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02252458</url>
  </required_header>
  <id_info>
    <org_study_id>2014-054</org_study_id>
    <nct_id>NCT02252458</nct_id>
  </id_info>
  <brief_title>Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?</brief_title>
  <acronym>FentaOIH-V</acronym>
  <official_title>Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers? A Prospective, Randomized, Double-blinded Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether two clinically sensible dose regimen of
      fentanyl (low dose vs. high dose) lead to different pain scores as measured by the nonverbal
      rating scale (NRS) in healthy volunteers at 4.5 to 6.5 hours after fentanyl application. Pain
      modalities tested will include transdermal electrical stimulation and cold pressor pain.

      The investigators hypothesize that the high dose fentanyl group will have an increase of
      approximately 20% in the NRS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>COMPOSITE of pain scores as measured by the nonverbal rating scale (NRS) at 15 minute intervals within the timeframe specified below.</measure>
    <time_frame>4.5 to 6.5h after begin of fentanyl infusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain as measured by the nonverbal rating scale</measure>
    <time_frame>0-2h after begin of fentanyl infusion at 15 min intervals</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cold pressor pain</measure>
    <time_frame>at -15min, 1h, 2h, 3h, 4h, 5h, 6h, 6h30min after begin of infusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lab values (B-endorphin, fentanyl plasma Levels, potentially Adrenocorticotropic hormone (ACTH) / cortisol)</measure>
    <time_frame>-15min, -10min, -5 min, 0 min, 15 min, 30 min, 45min, 1h, 1h 30min, 2h, 4h 30min, 4h 35min, 4h 40min, 4h 45min, 5h, 5h 30min, 6h, 6h 30min after begin of infusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pupillary dilation response</measure>
    <time_frame>baseline and at 4.5h after begin of infusion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fentanyl high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fentanyl 10mcg/kg of bodyweight</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl low dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl 1mcg/kg of bodyweight</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Fentanyl high dose</arm_group_label>
    <arm_group_label>Fentanyl low dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy (ASA I-II) male volunteers

          -  Age &gt; 18 years

          -  BMI 18 - 25 kg/m2

        Exclusion Criteria:

          -  Volunteers unable to give written informed consent

          -  Known drug allergies or intolerance to fentanyl

          -  Known drug allergies or intolerance to morphine and other opiates

          -  Recreational drug addiction or abuse

          -  Opiate use in the last month

          -  Volunteers taking confounding medication (analgesics, antihistamines, calcium or
             potassium channel blockers) in the last month

          -  History of motion sickness, neuropathy, chronic pain, neuromuscular or psychiatric
             disease

          -  Patients with renal failure (clearance &lt; 30 ml/min)

          -  obstructive sleep apnea syndrome (OSAS)

          -  Indication for Rapid Sequence Induction

          -  Patients not understanding German, French, Italian or English
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilhelm Ruppen, PD Dr., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Basel, Dep. of Anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesia, University of Basel Hospital</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2014</study_first_submitted>
  <study_first_submitted_qc>September 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2014</study_first_posted>
  <last_update_submitted>January 8, 2015</last_update_submitted>
  <last_update_submitted_qc>January 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Opioid induced hyperalgesia</keyword>
  <keyword>Fentanyl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

